On September 7, 2021 Systems Oncology LLC, a privately held biopharmaceutical company developing a new class of multi-modal RNA therapeutics, reported that the management team will be presenting and participating at the following upcoming conferences (Press release, Systems Oncology, SEP 7, 2021, View Source [SID1234587336]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

H.C. Wainwright 23rd Annual Global Investment Conference
Company Presentation
Presented by Dr. Spyro Mousses, CEO
September 10th, 2021, 3:00pm ET
Virtual

Wells Fargo 2021 Virtual Healthcare Conference
Fireside Chat
Presented by Dr. Spyro Mousses, CEO
September 10th, 2021, 4:00pm ET
Virtual

TIDES USA Conference
Arromer – Receptor Directed Delivery for Ultra-precise RNAi Multi-targeting
Presented by Dr. Spyro Mousses, CEO
September 23rd, 2021, 12:20pm ET
Boston, MA

Archived replays of the webcasts following each event will be available on Systems Oncology’s website at View Source